• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.33% Nasdaq Down 1.33%

    More On UCBJY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    UCB S.A. (UCBJY)

    -Other OTC
    39.78 0.00(0.00%) 1:48PM EST
    Add to Portfolio
    Prev Close:39.78
    Open:39.78
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:39.78 - 39.78
    52wk Range:35.07 - 49.29
    Volume:400
    Avg Vol (3m):597
    Market Cap:15.47B
    P/E (ttm):46.31
    EPS (ttm):0.86
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for UCBJY

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.56
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    UCB S.A., a global biopharmaceutical company, focuses on central nervous system disorders and immunology diseases. The company’s core products include Cimzia for inflammatory arthritis indications and Crohn’s disease; Vimpat for epilepsy... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback